SEGMENT INFORMATION (Tables)

3 Months Ended

Oct. 31, 2012

The following table presents sales and segment profit from continuing operations by business segment reconciled to earnings from continuing operations before income taxes, for the three months ended October 31, 2012 and October 31, 2011. The Life Sciences and Industrial results for the three months ended October 31, 2011 have been restated to reflect the change in allocation of certain shared expenses on a continuing operations basis.



	Three Months Ended
	Oct 31, 2012			Oct 31, 2011
SALES:
Life Sciences	$	299,951		$	301,754
Industrial	327,649			349,508
Total	$	627,600		$	651,262
SEGMENT PROFIT:
Life Sciences	$	69,842		$	79,717
Industrial	52,766			43,635
Total segment profit	122,608			123,352
Corporate Services Group	14,065			15,701
Operating profit	108,543			107,651
ROTC	4,274			22,984
Interest (income)/expense, net	(568		)	5,945
Earnings from continuing operations before income taxes	$	104,837		$	78,722

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details